(VELA) Study of BLU-222 in Advanced Solid Tumors
Blueprint Medicines Corporation
Blueprint Medicines Corporation
OHSU Knight Cancer Institute
Emory University
GOG Foundation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
AGO Study Group
National Institutes of Health Clinical Center (CC)